IndraLab

Statements


| 3

reach
"Through deubiquitination, USP8 prevents MUC12 degradation, promoting tumor growth and malignancy [22]."

reach
"Consequently, targeting USP8 improved the efficacy of BC immunotherapy and suppressed tumor progression."

reach
"Indeed, blockade of USP8 by DUBs-IN-2 synergizes with ICB to retard tumor growth [22]."